Drug-maker Mallinckrodt may renege on $1.7 billion opioid settlement. Mallinckrodt says it is considering its financial alternatives, including a second bankruptcy, and might not make a $200.

Drug-maker Mallinckrodt may renege on $1.7 billion opioid settlement. Mallinckrodt says it is considering its financial alternatives, including a second bankruptcy, and might not make a $200.